2-(3-Fluoro-4-((methylsulfonyl)methyl)phenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 95%, 5g

4-ethoxy-3-{1-methyl-7-oxo-3-propyl-1H,4H,7H-pyrazolo[4,3-d]pyrimidin-5-yl}benzene-1-sulfonyl chloride, 97%, 10g

(6-(Aminomethyl)pyridin-2-yl)methanol hydrochloride, 95+%, 10g

5-Bromo-3-methyl-isothiazole-4-carboxylic acid, 95.0%, 250mg

2-(Morpholinothio)benzothiazole>97.0%(GC)500g

Bolsa homogeneizadora, 3500 ml, 380 mm, Altura, 510 mm, 500 Pieza(s)

8-Oxabicyclo[3.2.1]octan-3-amine hydrochloride, 95.0%, 50mg

(R)-3-(((Benzyloxy)carbonyl)amino)butanoic acid, 95.0%, 5g

4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)fluorobenzene, 97.0%, 1g

(S)-2-Amino-2-(4-bromophenyl)acetic acid, 95.0%, 500mg

Famoxadone>95.0%(HPLC)(qNMR)5g

(3-Methoxyphenyl)acetaldehyde, 95.0%, 1g

Embudos con nervaduras, 210 mm, 1 Pieza